Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

On the Application of a Diffusive Memristor Compact Model to Neuromorphic Circuits.

Cisternas Ferri A, Rapoport A, Fierens PI, Patterson GA, Miranda E, Suñé J.

Materials (Basel). 2019 Jul 13;12(14). pii: E2260. doi: 10.3390/ma12142260.

2.

Impact of the precursor chemistry and process conditions on the cell-to-cell variability in 1T-1R based HfO2 RRAM devices.

Grossi A, Perez E, Zambelli C, Olivo P, Miranda E, Roelofs R, Woodruff J, Raisanen P, Li W, Givens M, Costina I, Schubert MA, Wenger C.

Sci Rep. 2018 Jul 24;8(1):11160. doi: 10.1038/s41598-018-29548-7.

3.

Silicon Oxide (SiOx ): A Promising Material for Resistance Switching?

Mehonic A, Shluger AL, Gao D, Valov I, Miranda E, Ielmini D, Bricalli A, Ambrosi E, Li C, Yang JJ, Xia Q, Kenyon AJ.

Adv Mater. 2018 Oct;30(43):e1801187. doi: 10.1002/adma.201801187. Epub 2018 Jun 29. Review.

PMID:
29957849
4.

Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.

Forte N, Livanos M, Miranda E, Morais M, Yang X, Rajkumar VS, Chester KA, Chudasama V, Baker JR.

Bioconjug Chem. 2018 Feb 21;29(2):486-492. doi: 10.1021/acs.bioconjchem.7b00795. Epub 2018 Jan 31.

5.

Investigation on the Conductive Filament Growth Dynamics in Resistive Switching Memory via a Universal Monte Carlo Simulator.

Li Y, Zhang M, Long S, Teng J, Liu Q, Lv H, Miranda E, Suñé J, Liu M.

Sci Rep. 2017 Sep 11;7(1):11204. doi: 10.1038/s41598-017-11165-5.

6.

Analysis on the Filament Structure Evolution in Reset Transition of Cu/HfO2/Pt RRAM Device.

Zhang M, Long S, Li Y, Liu Q, Lv H, Miranda E, Suñé J, Liu M.

Nanoscale Res Lett. 2016 Dec;11(1):269. doi: 10.1186/s11671-016-1484-8. Epub 2016 May 25.

7.

Statistical characteristics of reset switching in Cu/HfO2/Pt resistive switching memory.

Zhang M, Long S, Wang G, Liu R, Xu X, Li Y, Xu D, Liu Q, Lv H, Miranda E, Suñé J, Liu M.

Nanoscale Res Lett. 2014 Dec;9(1):2500. doi: 10.1186/1556-276X-9-694. Epub 2014 Dec 23.

8.

A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.

Maruani A, Smith ME, Miranda E, Chester KA, Chudasama V, Caddick S.

Nat Commun. 2015 Mar 31;6:6645. doi: 10.1038/ncomms7645.

9.

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.

Goldstein R, Sosabowski J, Livanos M, Leyton J, Vigor K, Bhavsar G, Nagy-Davidescu G, Rashid M, Miranda E, Yeung J, Tolner B, Plückthun A, Mather S, Meyer T, Chester K.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):288-301. doi: 10.1007/s00259-014-2940-2. Epub 2014 Nov 13.

10.

Homogeneous bispecifics by disulfide bridging.

Hull EA, Livanos M, Miranda E, Smith ME, Chester KA, Baker JR.

Bioconjug Chem. 2014 Aug 20;25(8):1395-401. doi: 10.1021/bc5002467. Epub 2014 Aug 1.

11.

Voltage and power-controlled regimes in the progressive unipolar RESET transition of HfO₂-based RRAM.

Long S, Perniola L, Cagli C, Buckley J, Lian X, Miranda E, Pan F, Liu M, Suñé J.

Sci Rep. 2013 Oct 14;3:2929. doi: 10.1038/srep02929.

12.

Generation and characterization of a diabody targeting the αvβ6 integrin.

Kogelberg H, Miranda E, Burnet J, Ellison D, Tolner B, Foster J, Picón C, Thomas GJ, Meyer T, Marshall JF, Mather SJ, Chester K.

PLoS One. 2013 Sep 4;8(9):e73260. doi: 10.1371/journal.pone.0073260. eCollection 2013.

13.

Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation.

Castañeda L, Maruani A, Schumacher FF, Miranda E, Chudasama V, Chester KA, Baker JR, Smith ME, Caddick S.

Chem Commun (Camb). 2013 Sep 25;49(74):8187-9. doi: 10.1039/c3cc45220d.

14.

Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region.

Miranda E, Maya Pineda H, Öberg D, Cherubini G, Garate Z, Lemoine NR, Halldén G.

PLoS One. 2012;7(10):e46617. doi: 10.1371/journal.pone.0046617. Epub 2012 Oct 3.

15.

[Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients].

Ramos C, Rozen E, León M, Martínez T A, Olarte I, Catellanos H, Martínez C, Montaño E, Kassack I J, Zamora J, Miranda E, De la Ros A, Gutiérrez M, Collazo J.

Rev Med Chil. 2011 Sep;139(9):1135-42. doi: /S0034-98872011000900004. Epub 2011 Nov 17. Spanish.

16.

MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma.

Olarte I, Martinez A, Ramos-Peñafiel C, Castellanos-Sinco H, Zamora J, Collazo-Jaloma J, Gutiérrez M, Gutiérrez-Kobeh L, Chavez-Olmos P, Manzanilla H, Garrido-Guerrero E, Ordoñez-Razo RM, Miranda EI.

Hematology. 2011 Nov;16(6):368-72. doi: 10.1179/102453311X13085644680384.

PMID:
22183072
17.

Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.

Radhakrishnan S, Miranda E, Ekblad M, Holford A, Pizarro MT, Lemoine NR, Halldén G.

Hum Gene Ther. 2010 Oct;21(10):1311-25. doi: 10.1089/hum.2010.019.

PMID:
20497039
18.

MAGE, biological functions and potential clinical applications.

Miranda EI.

Leuk Res. 2010 Sep;34(9):1121-2. doi: 10.1016/j.leukres.2010.03.045. Epub 2010 May 7. No abstract available.

PMID:
20452019
19.

Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

Leitner S, Sweeney K, Oberg D, Davies D, Miranda E, Lemoine NR, Halldén G.

Clin Cancer Res. 2009 Mar 1;15(5):1730-40. doi: 10.1158/1078-0432.CCR-08-2008. Epub 2009 Feb 17.

20.

The implantation of Taenia solium metacestodes in mice induces down-modulation of T-cell proliferation and cytokine production.

Hernández-Mendoza L, Molinari JL, Garrido E, Cortés I, Solano S, Miranda E, Tato P.

Parasitol Res. 2005 Mar;95(4):256-65. Epub 2005 Jan 28.

PMID:
15678353

Supplemental Content

Loading ...
Support Center